136 related articles for article (PubMed ID: 34596127)
1. Identification of key genes in osteosarcoma - before and after CDK7 treatment.
An Y; Wang Y; Xu G; Liao Y; Huang G; Jin X; Xie C; Li Q; Yin D
Medicine (Baltimore); 2021 Oct; 100(39):e27304. PubMed ID: 34596127
[TBL] [Abstract][Full Text] [Related]
2. Targeting Super-Enhancer-Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor.
Zhang J; Liu W; Zou C; Zhao Z; Lai Y; Shi Z; Xie X; Huang G; Wang Y; Zhang X; Fan Z; Su Q; Yin J; Shen J
Clin Cancer Res; 2020 Jun; 26(11):2681-2692. PubMed ID: 31937612
[TBL] [Abstract][Full Text] [Related]
3. Identification of key biomarkers and functional pathways in osteosarcomas with lung metastasis: Evidence from bioinformatics analysis.
Liu D; Zhou R; Zhou A
Medicine (Baltimore); 2021 Feb; 100(6):e24471. PubMed ID: 33578541
[TBL] [Abstract][Full Text] [Related]
4. Identification of genes associated with methotrexate resistance in methotrexate-resistant osteosarcoma cell lines.
Yang XR; Xiong Y; Duan H; Gong RR
J Orthop Surg Res; 2015 Sep; 10():136. PubMed ID: 26337976
[TBL] [Abstract][Full Text] [Related]
5. Investigation of crucial genes and microRNAs in conventional osteosarcoma using gene expression profiling analysis.
Peng C; Yang Q; Wei B; Yuan B; Liu Y; Li Y; Gu D; Yin G; Wang B; Xu D; Zhang X; Kong D
Mol Med Rep; 2017 Nov; 16(5):7617-7624. PubMed ID: 28944822
[TBL] [Abstract][Full Text] [Related]
6. [Bioinformatics analysis of differently expressed genes in osteoblastic sarcoma and screening of key genes].
Shen RK; Huang Z; Zhu X; Lin JH
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):147-154. PubMed ID: 35184458
[No Abstract] [Full Text] [Related]
7. Identification of Key Genes and Pathways in Osteosarcoma by Bioinformatics Analysis.
Chen X; Zhang N; Zheng Y; Tong Z; Yang T; Kang X; He Y; Dong L
Comput Math Methods Med; 2022; 2022():7549894. PubMed ID: 35075370
[TBL] [Abstract][Full Text] [Related]
8. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential key genes and functional role of CENPF in osteosarcoma using bioinformatics and experimental analysis.
Ma Y; Guo J; Li D; Cai X
Exp Ther Med; 2022 Jan; 23(1):80. PubMed ID: 34934449
[TBL] [Abstract][Full Text] [Related]
10. Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays.
Shen H; Wang W; Ni B; Zou Q; Lu H; Wang Z
Int J Mol Med; 2018 Jul; 42(1):21-30. PubMed ID: 29620143
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling analysis of the role of miR-22 in clear cell ovarian cancer.
Zhen YB; Guo XL; Xu B; Zhao HW; Xu CJ
Neoplasma; 2016; 63(6):856-864. PubMed ID: 27565323
[TBL] [Abstract][Full Text] [Related]
12. Screening and Interaction Analysis of Key Genes in miR-542-3p Over- Expressed Osteosarcoma Cells by Bioinformatics.
Li Z; Zhang P; Feng F; Zhang Q
Comb Chem High Throughput Screen; 2020; 23(5):411-418. PubMed ID: 32233998
[TBL] [Abstract][Full Text] [Related]
13. Identification of Key Genes and miRNAs in Osteosarcoma Patients with Chemoresistance by Bioinformatics Analysis.
Xie B; Li Y; Zhao R; Xu Y; Wu Y; Wang J; Xia D; Han W; Chen D
Biomed Res Int; 2018; 2018():4761064. PubMed ID: 29850522
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential crucial genes and key pathways in osteosarcoma.
Liu J; Wu S; Xie X; Wang Z; Lei Q
Hereditas; 2020 Jul; 157(1):29. PubMed ID: 32665038
[TBL] [Abstract][Full Text] [Related]
15. Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.
Chen B; Sun D; Qin X; Gao XH
Invest New Drugs; 2021 Aug; 39(4):928-948. PubMed ID: 33501609
[TBL] [Abstract][Full Text] [Related]
16. Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling.
Fan H; Lu S; Wang S; Zhang S
Mol Med Rep; 2019 Aug; 20(2):915-930. PubMed ID: 31173206
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of AURKA/PLK4 in quiescence and senescence of osteosarcoma U2OS cells.
Xie XL; Zhu HX; Li YM; Chen DT; Fan TY
Cell Cycle; 2020 Apr; 19(8):884-894. PubMed ID: 32200684
[TBL] [Abstract][Full Text] [Related]
18.
Li S; Wu X; Pei Y; Wang W; Zheng K; Qiu E; Zhang X
DNA Cell Biol; 2019 Nov; 38(11):1323-1337. PubMed ID: 31536386
[TBL] [Abstract][Full Text] [Related]
19. Identification of CD20, ECM, and ITGA as Biomarkers for Osteosarcoma by Integrating Transcriptome Analysis.
Wang DW; Yu SY; Cao Y; Yang L; Liu W; Er XQ; Yao GJ; Bi ZG
Med Sci Monit; 2016 Jun; 22():2075-85. PubMed ID: 27314445
[TBL] [Abstract][Full Text] [Related]
20. Identification of hub genes associated with bladder cancer using bioinformatic analyses.
Zheng W; Zhao Y; Wang T; Zhao X; Tan Z
Transl Cancer Res; 2022 May; 11(5):1330-1343. PubMed ID: 35706790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]